PhD Trials® has acquired inovapotek for an undisclosed amount. Inovapotek is a Contract Research Organization (CRO) specializing in customized R&D, testing, regulatory, and consulting services for the Personal Care, Pharmaceutical, Medical Devices, and Food Supplements industries. This acquisition marks a strategic expansion for PhD Trials® within the scientific research and product development sector.
Inovapotek provides a comprehensive suite of services globally, ranging from formulation development, quality control, and stability studies to safety, efficacy, and consumer testing. The company also offers regulatory affairs support for creating innovative, stable, safe, effective, and compliant products. Its operations are driven by principles of scientific excellence, innovation, client focus, commitment, and strong ethics, ensuring the development and testing of products meet both regulatory demands and consumer needs for a diverse client base.
The acquisition of inovapotek by PhD Trials® is expected to create significant synergies, enhancing the combined entity's capabilities across various product lifecycle stages. By integrating inovapotek's specialized expertise in areas such as SPF testing, sensorial analysis, and R&D projects for pharmaceuticals and food supplements, PhD Trials® aims to broaden its service portfolio and strengthen its position as a leading provider of research and development solutions. This move is poised to offer clients a more extensive and integrated range of services, from initial concept to market readiness.
The combined entity is set to leverage inovapotek's scientific vanguard approach to promote the development of innovative products. This strategic integration is anticipated to result in enhanced service offerings, deeper scientific expertise, and a more robust global presence, ultimately benefiting clients seeking comprehensive support for their product development and regulatory compliance needs.